Abstract In vivo and ex vivo models of reoviral encephalitis were utilized to delineate the contribution of type I interferon (IFN) 
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Introduction
Innate immune responses, including inflammatory cytokine and chemokine production, mark the earliest phase of the host response to an invading organism. The type I interferon (IFN) genes, IFN-α and IFN-β, are induced in response to viral infection via activation of IFN regulatory factor 3 (IRF3) and nuclear factor-kappa B (NF-κB) transcription factors (Randall and Goodbourn 2008) . These cytokines are then secreted from cells to act in an autocrine and paracrine manner through a common heterodimeric type I interferon receptor (IFNAR). Agonist-receptor binding results in activation of transcription factors STAT1 and STAT2 (signal transducer and activator of transcription) which, along with IRF9, form a heterotrimeric transcription factor complex known as interferon-stimulated gene factor 3 (ISGF3). ISGF3 translocates to the nucleus where it binds to IFN-stimulated response elements to induce transcription of hundreds of IFN-stimulated genes (ISGs). The cellular "antiviral state" is established through the combined functionality of ISG gene products. Several ISGs have direct antiviral functions while others modulate the immune system by activating effector cells and promoting the development of an acquired immune response. Mammalian orthoreoviruses (reoviruses) are non-enveloped, icosahedral viruses with a genome consisting of ten doublestranded RNA segments (Tyler et al. 2001) . Reoviruses have the capacity to induce apoptosis in both cultured cells in vitro (Clarke and Tyler 2003) and target organs in vivo (Clarke and Tyler 2009) . Reoviral infection has served as a versatile model system for the study of viral pathogenesis and antiviral immunity in the brain (encephalitis; Clarke et al. 2005) , spinal cord (myelitis; Goody et al. 2008) , and heart (myocarditis; Sherry 2002) . The potential with which a given reovirus strain induces myocarditis is negatively correlated to its induction of, and sensitivity to, IFN-α/β (Sherry et al. 1998) . Furthermore, the IFN-α/β response is critical for myocardiocyte protection against reovirus replication both in vitro and in vivo (Sherry 2009 ). The importance of the IFN response in limiting reovirus replication and pathogenesis is also evidenced by in vivo models of peroral inoculation with reovirus serotype 1 strain Lang (T1L).
For instance, systemic T1L infection and animal lethality is inhibited via IFN-α/β release from intestinal dendritic cells residing in Peyer's patches (Johansson et al. 2007) . Similarly, IRF3 plays a role in restricting systemic T1L replication, limiting pathological changes in the heart, and preventing associated mortality (Holm et al. 2010) .
In contrast to the heart, the role of IFN in reovirus infections of the central nervous system (CNS) is poorly understood. Reovirus infection of the brain (Tyler et al. 2010) and spinal cord (S.A.S., personal communication) is associated with increased expression of ISGs. The profile of ISGs induced in the brain during reovirus encephalitis is remarkably similar to that seen following infection of the brain with other neurotropic viruses, including Venezuelan equine encephalitis virus (VEEV) (Sharma et al. 2008 ) and dengue virus type 1 (Bordignon et al. 2008) , suggesting a consistent host response to viral infections of the brain. We have previously demonstrated that, in brains infected with reovirus serotype 3 strain Abney (T3A), (STAT1) is phosphorylated at sites critical for its transcriptional activity (Goody et al. 2007) . Mice lacking STAT1 demonstrate increased susceptibility to reovirus infection, increased mortality, and higher viral titers in the brain compared to wildtype controls. However, the role of IFN in virus-induced brain injury and disease was not described in these studies and the cause of death was not established. In the present study, we sought to directly assess the role of IFN in the virally infected host in terms of CNS-specific and -systemic viral replication/ pathogenesis by utilizing ex vivo and in vivo models of reovirus infection.
Herein, we demonstrate that reovirus infection induces CNS expression of type I interferon genes (i.e., IFN-α/β) and the interferon-stimulated gene, myxovirus-resistance protein (Mx1). Mice lacking functional IFN-α/β receptor (IFNAR −/− ) have accelerated mortality and markedly increased viral titers in both brain and peripheral organs following reovirus infection. IFNAR −/− mice infected with T3 reovirus show an extended pattern of viral tropism in the CNS compared to congenic wildtype (B6wt) mice, as evidenced by the previously unreported capacity of the virus to infect neurons of the dentate gyrus and both ependymal and meningeal cells. We utilized a novel ex vivo brain slice culture system to reveal that IFN is produced locally in the CNS and does not depend upon extraneuronal aspects of viral infection (e.g., infiltrating inflammatory cells). This brain-derived IFN limits viral replication and reduces viral-induced apoptotic injury within the CNS. Overall, these data indicate that reovirus infection (both in vivo and ex vivo) induces a robust IFN response, which serves to restrict viral tropism, limit viral growth, and reduce consequent apoptosis within the CNS.
Results
IFN signaling occurs in reovirus-infected brain tissue
To determine whether reovirus induces a type I IFN response in the brain, outbred 2-day-old Swiss Webster mice were intracranially (i.c.) injected with T3A (1,000 pfu), T1L (1,000 pfu), or phosphate buffered saline (PBS) only (mock) and total brain RNA was isolated for reverse transcription polymerase chain reaction (RT-PCR) amplification of IFN-α/β transcripts. Infection with either reovirus serotype induced significant upregulation of IFN-α (Fig. 1a) and IFN-β (Fig. 1b) Fig. 3a) , T3A (Fig. 3b) , and T3D (Fig. 3c ). T3D is a neurotropic reovirus strain that is not extensively spread through the hematogenous route. However, in the absence of IFNAR, T3D enters the blood and replicates to high titers in several organs. Overall, this data indicates that viral replication and spread is controlled by the host IFN response.
Reovirus induces acute liver and intestinal injury but does not accelerate neuronal injury in IFNAR −/− mice At 4 dpi, grossly abnormal liver (Fig. 4a, 
days (N≥8). IFNAR
−/− and B6wt survival distributions were significantly different (p<0.0001), regardless of the reovirus serotype injected. All virus serotypes were 100% lethal in IFNAR −/− animals by day 6. In contrast, 87% of T1L-infected B6wt animals survived to the study endpoint and T3-infected B6wt animals lived until ∼11 dpi tissue-specific immune responses in isolation from the whole animal (Dionne et al. 2011) . Utilization of this system allowed us to study the potential role of IFN in the brain's innate immunity against reovirus, independent from events occurring outside of the CNS. To confirm that T3A-induced IFN-β expression occurred ex vivo, BSCs were prepared from Swiss Webster mice and immediately infected with T3 reovirus. Media was changed ∼12 h later and every 2 days thereafter. Media, from experimentally similar wells, was pooled at 5 or 9 dpi for three independent experiments and serially diluted for enzyme-linked immunosorbent assay (ELISA)-based quantification of IFN-β release by mock-or T3A-infected BSCs. In T3A-infected samples, IFN-β protein was detected in 7-9 dpi media (19.98±20.34 pg/mL), but not 3-5 dpi media. IFN-β was not detected in the media from mock samples suggesting that BSCs release little to no IFN-β at baseline. This study confirmed that cells, resident to the CNS, produce IFN-β at the protein level in response to T3A reovirus.
We next sought to investigate, across an extended time frame, whether viral replication and apoptosis would be more severe in reovirus-infected slices prepared from IFNAR −/− mice as compared to B6wt controls. Quantification of the reovirus L1 gene segment by RT-PCR revealed significantly elevated viral load in T3A-and T3D-infected IFNAR −/− slices, compared to B6wt slices by 7 dpi (Fig. 5a ).
T3A-infected IFNAR −/− BSCs had 4.3-, 4.5 (p=0.009)-, and 7 (p=0.024)-fold greater expression of the viral L1 gene segment at 5, 7, and 9 dpi respectively, compared to T3A-infected B6wt BSCs. In T3D experiments, virus-infected IFNAR −/− BSCs had 5.0-, 6.5 (p=0.015)-, and 17 (p= 0.036)-fold greater viral gene expression at the same time points. Overall, these data indicate that innate IFN signaling plays a key role in restricting viral replication in brain tissue. Virus-induced tissue apoptosis can be quantitatively measured in BSC slices via fluorogenic Caspase 3 activity assay of BSC lysates (Dionne et al. 2011) . Utilizing this methodology, virus-induced apoptosis was found to be more pronounced in IFNAR −/− BSCs at 7, 9, and 11 dpi, with a significant difference (p=0.01) occurring between mock and IFNAR −/− samples at 11 dpi (Fig. 5b) . These data (1,000 pfu) and the pattern of viral infection was examined by immunofluorescent staining of σ3 viral antigen. We have previously shown that, in wildtype mice, T3 reoviruses specifically infect neurons of the lateral thalamus, cingulate cortex, and CA3 region of the hippocampus (Oberhaus et al. 1997; Richardson-Burns et al. 2002) . Consistent with these results, effective T3D infection of the CA3 is seen in B6wt animals by 11 dpi, but not as early as 4 dpi (Fig. 6a) . In contrast, viral antigen is found in the CA3 of IFNAR −/− mice by 4 dpi. At this time point, there is also evidence of reovirus antigen throughout the IFNAR −/− cortex, thalamus, and hippocampus. Dentate infection does not occur in T3D-infected B6wt mice even at late times post-infection when viral titer approaches 10 9 pfu/mL; thus, the presence of reovirus antigen in the dentate gyrus in IFNAR −/− mice is indicative of extended T3D tropism. Dual fluorescence imaging of reovirus antigen and NeuN neuronal marker confirmed that enhancement of viral replication in IFNAR −/− mice occurred specifically in neurons of the CA3 and dentate brain regions (Fig. 6b) . These data indicate that IFN serves to limit T3 reovirus neurotropism in the brain. T1L does not animals and fixed in 10% formalin overnight, paraffin embedded, and sectioned at 6 μm prior to immunofluorescence labeling. Reovirus σ3 antigen (monoclonal; red) was detected in CA3 and dentate of IFNAR −/− mice at 4 dpi. In comparison, B6wt mice have reovirus antigen in the CA3 only at late times post-infection (i.e., 11 dpi) and do not develop detectable levels of reovirus antigen in the dentate; ×100 magnification. Insets depict reovirus-positive cells at ×2 original magnification (a). To confirm that the infected IFNAR −/− cells are neurons, histological sections were colabeled with reovirus (polyclonal; red) and NeuN neuronal marker (monoclonal; green). ×630 magnification (b). Reovirus σ3 antigen (monoclonal; red) was found at high levels in the meninges and ependyma of IFNAR −/− animals. These cell types were not infected at any timepoint in B6wt animals; ×100 magnification (c). GFAP-positive (monoclonal; green) astrocytes (located within the parenchyma deep to meningeal and ependymal cell layers), were not reovirus antigen-positive (polyclonal; red) regardless of mouse genetic background; ×400 magnification (d) normally infect neurons in wildtype mouse brains and neuronal tropism was not observed in IFNAR −/− mice following inoculation of T1L (data not shown). We next hypothesized that the absence of IFN would also render other CNS cell populations in the brain susceptible to infection. We found reovirus antigen in both meningeal and ependymal cells in T3D-infected IFNAR −/− mice, but not B6wt mice (Fig. 6c) . Pronounced infection of these cell types was also seen in IFNAR −/− , but not B6wt, mice injected with 100 pfu T3A or 1000 pfu T1L at 4 dpi (data not shown). To investigate whether tropism was also extended to glia, astrocytes were labeled with monoclonal glial fibrillary acidic protein (GFAP) antibody (Fig. 6d) . T3D viral antigen was not evident in IFNAR −/− or B6wt astrocytes, suggesting that reovirus tropism is limited in this cell type by a mechanism unrelated to IFN signaling. Overall, these data indicate that T3 reoviruses are genetically capable of infecting ependymal and meningeal cell types in addition to neurons in multiple brain regions and that it is the host IFN response that restricts such tropism.
Discussion
The role of IFN during viral infection of the brain remains incompletely understood. In this report, we demonstrate for the first time that reovirus T1 and T3 strains induce the expression of the type I IFN genes, IFN-α/β, and the ISG Mx1 in the brain following infection (Fig. 1 ). We also show that i.c. inoculation of IFNAR −/− mice with reovirus results in accelerated lethality ( Fig. 2 ) and is associated with higher viral titers in the CNS and peripheral organs (Fig. 3) , indicating that IFN signaling plays a key role in reovirus pathogenesis. Death of infected IFNAR −/− mice likely resulted from hepatic and/or intestinal pathology and subsequent bacterial sepsis (Fig. 4) . However, we utilized an ex vivo brain slice model of reovirus infection to demonstrate that IFN is produced locally within the CNS to help control CNS viral replication and tissue injury (Fig. 5) . Finally, we show that increased viral titer in the IFNAR −/− brain is associated with extended cellular tropism by demonstrating the presence of T3D within neuronal populations and non-neuronal populations (i.e., ependymal and meninges cells) not typically infected by T3 reoviruses (Fig. 6 ). Local production of type I interferon within the CNS has been reported following infection with herpes simplex virus (Menachery et al. 2010 ), Theiler's murine encephalitis virus (TMEV; Rubio et al. 2010 ), La Crosse virus (Delhaye et al. 2006 ), vesicular stomatitis virus (Detje et al. 2009 ), Semiliki Forest virus (SFV; Fragkoudis et al. 2007) , and the neurotropic coronavirus mouse hepatitis virus (MHV; Roth-Cross et al. 2008) . In the present study, we demonstrate that both T3 and T1 reovirus strains induce IFN expression in the brain. The T3 response was more pronounced than the T1 response possibly because the T3 virus replicates to higher titers within the brain. Alternatively, the T1L reovirus strain could have the capacity to subvert the IFN response in the brain by modulating the subcellular localization of IRF9, as was recently described in vitro (Zurney et al. 2009 ).
Expression of ISGs has also been reported in the brain after infection with several viruses including lymphocytic choriomeningitis virus (Wacher et al. 2007 ), West Nile virus (WNV; Wacher et al. 2007) , dengue virus type-1 (Bordignon et al. 2008) , and VEEV (Sharma et al. 2008 ). These results demonstrate that IFN signaling is activated in the brain following infection with a wide variety of viruses. Our results are also consistent with other reports highlighting the importance of IFN-α/β signaling in the control of viral replication in the CNS (Randall and Goodbourn 2008) . For example, increases in brain viral load have been reported following infection of IFNAR-deficient mice with Sindbis virus (Ryman et al. 2000) , SFV (Fragkoudis et al. 2007 ), VEEV (Grieder and Vogel 1999) , MHV (Ireland et al. 2008) , and WNV (Samuel and Diamond 2005) . Deficiencies in the expression of other proteins involved in IFN signaling including STAT1, IRF3, and IRF7 have similar effects on viral replication in the brain (Daffis et al. 2008; Goody et al. 2007; Holm et al. 2010; Menachery et al. 2010) .
To investigate the role of IFN in virus-induced disease within the CNS, we utilized an ex vivo model of viral encephalitis. We showed that reovirus growth was significantly increased in slices derived from IFNAR −/− mice compared to slices derived from B6wt controls although the magnitude of this increase was not as dramatic as that seen in vivo. This discrepancy is likely due to viral reseeding that occurs in the intact animal, but not the ex vivo culture system. In addition, we saw an increase in Caspase 3 activity in reovirus-infected IFNAR −/− brain slices compared to infected B6wt controls. We have previously demonstrated that apoptosis is a primary mechanism of neuronal cell death and tissue injury during reovirus encephalitis (Oberhaus et al. 1997; Richardson-Burns et al. 2002) . Our results thus suggest that local IFN response within the brain is protective and serves to limit both viral growth and virus-induced tissue injury. In this report, we demonstrate extended reoviral tropism to peripheral organs of IFNAR −/− mice. Increased viral titers, associated with extended tropism, have also been noted following WNV infection of IFNAR-deficient mice, with increased infection of splenic macrophages, B cells, and T cells (Samuel and Diamond 2005) . Extended tissue tropism to the heart, intestine, stomach, lung, and kidney is seen following infection of IFNAR-deficient mice with MHV (Roth-Cross et al. 2008) . Similarly, SFV gains tropism to the heart, pancreas, adipose tissue, and muscle of IFNAR-deficient mice (Fragkoudis et al. 2007 ). In aggregate, these results indicate that the type I IFN response plays an important role in determining tissue tropism.
In the brain, we demonstrate, in the absence of IFNAR, expanded tropism of reovirus to a greater neuronal population, and to cells of the meninges and ependyma. Particularly striking is the extended tropism of T3 reovirus strains to ependymal cells (Fig. 6) . Early data suggested that T1L, but not T3 reovirus strains, induce hydrocephalus because T1 strains encode a unique viral hemagglutinin, which mediates high-affinity ependymal cell binding (Tardieu and Weiner 1982; Weiner et al. 1977 ). Our results demonstrate that in the absence of IFN, T3 reovirus strains can also infect and efficiently replicate within ependymal cells. In contrast, wildtype mice do not support reovirus infection within these cell types even at late time points post-infection when whole brain viral titers are in excess of 10 8 pfu/mL. Given these results, we conclude that T3 reovirus strains have the capacity to infect ependymal and meningeal cells; however, in the presence of the host IFN response viral replication is effectively inhibited in these cell types. Increased tropism to ependymal cells, in the absence of IFN signaling, has also been seen following infection of the brain with WNV (Samuel and Diamond 2005) , Sindbis virus (Ryman et al. 2000) , measles virus (Mrkic et al. 1998) , TMEV (Fiette et al. 1995) , and Semiliki forest virus (Fragkoudis et al. 2007 ). Taken together, our results and prior studies suggest that type I IFN plays a key role in protecting ependymal cells from infection by neurotropic viruses.
Our studies demonstrate the importance of IFN signaling in the virus-infected organism in general and in the brain in particular. An expanding body of literature now implicates a protective role for IFN during virus-induced CNS disease. IFN is already prescribed for the treatment of peripheral viral infections (i.e., human infection with hepatitis C). The demonstrated importance of IFN-α/β in controlling virus replication and virus-induced injury within the brain suggests that therapeutic IFN could benefit patients suffering from viral infections of the CNS.
Materials and methods
Viral stocks
T1L, T3A, and T3D are laboratory stocks derived via plaque purification and double passage in L929 cells. T3 strains were further purified via cesium chloride density gradient centrifugation.
In vivo studies
Swiss Webster outbred mice were obtained from Harlan Laboratories (Indianapolis, IN, USA) . Breeder pairs of type I IFNAR −/− were kindly provided by Ross Kedl (National Jewish Health; Denver, CO, USA). Congenic C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). All experiments were approved by the Institutional Animal Care and Use Committee and performed in an Association for Assessment and Accreditation of Laboratory Animal Care International-accredited animal facility. Two-day-old mice were i.c. inoculated with T1L (1,000 pfu), T3A (1,000 pfu into Swiss Webster mice; 100 pfu into IFNAR −/− and B6wt mice), or T3D (1,000 pfu) diluted in a 10-μl volume of PBS. Mock-infected mice received i.c. vehicle PBS at equal volume.
Preparation and infection of organotypic BSCs
Brain slice cultures were prepared from 2 to 3-day-old B6wt or IFNAR −/− mice in compliance with institutional procedural guidelines. Mice were euthanized by decapitation and brains rapidly removed into ice-cold slicing media (MEM, 10 mM Tris, 28 mM D-glucose, pH 7.2, equilibrated with 95% O2/5% CO2). Under semisterile conditions, the frontal cortex and cerebellum were removed and 400-μm coronal sections cut through cerebral regions containing hippocampus and thalamus using a vibrating-blade microtome (Leica VT1000S; Bannockburn, IL, USA). Four slices from a single animal were carefully positioned onto a single semiporous membrane insert (Millipore #PICMORG50; Billerica, MA, USA) according to the method of Stoppini et al. (1991) . Membranes were placed in 35 mm tissue culture dishes containing 1.2 mL serum containing media (Neurobasal supplemented with 10 mM HEPES, 1× B-27, 10% fetal bovine serum (FBS), 400 μM L-glutamine, 600 μM Glutamax, 60 U/mL penicillin, 60 μg/mL streptomycin, and 6 U/mL nystatin), such that slices were positioned at the media-air interface. Immediately after plating, slices were infected with 10 6 pfu T3A or T3D per slice. Virus was diluted into 20 μl PBS and applied dropwise to the top (air interface) of each slice. Mock infections were performed in a similar manner with PBS alone. Media was refreshed with 5% serum-containing media (5% FBS) approximately 12 h after slicing. All subsequent media changes were made with serum-free media every 2 days (i.e., 3, 5, 7, and 9 dpi). Cultures were maintained in a humidified incubator at 5% CO 2 and 36.5°C.
RNA purification from whole brains and BSCs
Mock-and T3A-infected brains were harvested from Swiss Webster mice at appropriate time points and immediately placed into RNAlater (Ambion; Foster City, CA, USA). Total RNA was purified by Dounce homogenization of the whole brain into 5 mL of Qiazol. This emulsion was transferred into a clean Falcon tube and set aside for at least 5 min before the addition of 1 mL chloroform. The mixture was shaken vigorously for 15 s and set aside for 5 min before centrifugation at 5,000×g for 15 min at 4°C. The upper 2 mL aqueous phase was then carefully transferred into a new tube containing 2 mL of 70% ethanol (prepared with diethyl pyrocarbonate-treated water). The solution was mixed and transferred onto an RNeasy Midi spin column (Qiagen; Germantown, MD, USA) and RNA was purified according to the manufacturer's specifications. To prevent degradation, RNase inhibitor was added and the sample was stored at −80°C.
For RNA purification from BSCs, four experimentally similar slices were washed three times in PBS and triturated in 600 μL RLT buffer (Qiagen; Germantown, MD, USA) containing 1% β-mercaptoethanol. Samples were stored at −80°C until lysate was processed through a QIAshredder (Qiagen; Germantown, MD, USA) and loaded onto an RNeasy Mini spin column (Qiagen; Germantown, MD, USA) for RNA purification according to the manufacturer's protocol. RNA samples were stored at −80°C until RT-PCR analysis.
RT-PCR quantification of gene transcripts
RT-PCR was utilized to quantify reovirus transcript in BSCderived total RNA samples. Two primers designated RV-3 (5′ CAT ATG ACT ACC ACT TTC CCG 3′) and RV-4 (5′ GCT ATG TCA TAT TTC CAT CCG 3′) were synthesized (Invitrogen; San Diego, CA, USA) to amplify a 298-bp segment of the reovirus L1 gene (Tyler et al. 1998) . Determination of viral burden, relative to a housekeeping gene, was achieved by concurrent amplification of mouse β-actin (SABiosciences primer #PPM02945A; Frederick, MD, USA). Purified RNA template, primers, RT-PCR master mix, and reverse transcriptase (iScript One-Step RT-PCR Kit with SYBR Green; Bio-Rad; Hercules, CA, USA) were mixed into a total volume of 20 μL. Forty cycles of PCR amplification were performed on a Bio-Rad CFX96 thermocycler (Hercules, CA, USA) as follows: cDNA synthesis at 50°C for 10 min, reverse transcriptase inactivation at 95°C for 5 min, denaturation at 95°C for 10 s, and annealing/ extension at 60°C for 30 s. Melt curve analysis confirmed absence of non-specific products and primer-dimers. C(t) values were converted to relative expression values on BioRad CFX Manager analysis software.
IFN-α, IFN-β, and Mx1 transcripts were quantified in whole brain-derived total RNA samples via qPCR. Purified RNA (2 μg) was first reverse transcribed to cDNA using the Applied Biosystems High Capacity cDNA Kit per manufacture directions (Carlsbad, CA, USA). IFN-α (#PPM03549E), IFN-β (#PPM03594B), and Mx1 (#PPM05520A) primers were purchased from SABiosciences (Frederick, MD, USA). Quantification of IFN-α, IFN-β, or Mx1 relative to a housekeeping gene was achieved by concurrent amplification of mouse β-actin (SABiosciences primer #PPM02945A; Frederick, MD, USA). cDNA (diluted 1:10), primers, and 2× Real Time SYBR green mix (SAbiosciences; Frederick, MD, USA) were mixed into a total volume of 25 μL. Forty cycles of PCR amplification were performed on a Bio-Rad CFX96 thermocycler (Hercules, CA, USA) as follows: Taq activation at 95°C for 10 min, denaturation at 95°C for 15 s, and annealing/extension at 60°C for 1 min. Melt curve analysis confirmed absence of non-specific products and primer dimers. C(t) values were converted to relative expression values on Bio-Rad CFX Manager analysis software.
Histological studies
Brain, liver, and intestinal tissue was immersed in 10% buffered formalin for no less than 12 h, embedded in paraffin, and serially sectioned into 6 μm-thick sections, and mounted onto slides. Tissue injury was assessed by H&E staining followed by light microscopy. To visualize infected cells, sections were desiccated at 50°C for 15 min then rehydrated in PBS over 30 min. Tissue was subjected to antigen retrieval (antigen unmasking solution; Vector Laboratories; Burlingame, CA, USA) and permeabilization/blocking (5% fetal bovine serum and 5% normal goat serum in 0.3% Triton/PBS) prior to incubation with primary antibodies: monoclonal reovirus σ3 antibody (4F2; 1:100), polyclonal reovirus antibody (1: 500), mouse anti-neuronal nuclear antibody (NeuN; 1:100; Millipore; Billerica, MA, USA), and/or mouse anti-GFAP (1:300; Sigma-Aldrich; St. Louis, MO, USA). Sections were then incubated with secondary antibodies: Alexa Fluor 488-conjugated goat anti-mouse or anti-rabbit IgG (1:200; Invitrogen; Carlsbad, CA, USA) and/or Cy3-conjugated AffiniPure goat anti-rabbit or anti-mouse IgG (1:300; Jackson ImmunoResearch; West Grove, PA, USA). For consistency, reovirus antigen was always labeled with Cy3. Nuclei were Hoechst stained (10 μg/mL; Immunochemistry Technology; Bloomington, MN, USA) prior to mounting sections with VectorShield Mounting Medium (Vector Laboratories; Burlingame, CA, USA). Slides were imaged on a Marianas fluorescence imaging workstation (Intelligent Imaging Innovation Inc, Denver, CO, USA) based on a Zeiss 300 M inverted microscope and CoolSnap HQ2 CCD camera, all controlled by Slidebook 4.2 software (Intelligent Imaging Innovation). Images are presented as obtained in Slidebook without changing "gamma" settings and without cropping.
IFN-β ELISA BSC media was screened for IFN-β protein synthesis/release with a Mouse Interferon Beta ELISA Kit (PBL Biomedial Laboratories, Piscataway NJ, USA) according to the manufacturer's protocol. Briefly, media from experimentally similar wells for individual BSC preps (N≥3) was pooled and pipetted into ELISA plates for a 2-h binding incubation. The plates were washed three times prior to 1-h incubation with detection antibody. Following another series of three washes, bound secondary antibody was detected by streptavidin-horseradish peroxidase and quantified on a microplate reader (Molecular Devices Emax; Sunnyvale, CA, USA). Absorbance was read at 450 nm (with wavelength correction at 560 nm). Quantification of IFN-β concentration was performed by placing absorbance values upon a standard curve (R 2 =0.996).
Viral titer plaque assays Viral titers were determined by plaque assays as previously described (Debiasi et al. 1999) . Briefly, L929 mouse fibroblasts, used for viral titer assays, were maintained in DMEM medium (supplemented with 10% heat-inactivated FBS and 4 mM L-glutamine). Brain and liver were washed three times with PBS and placed into 1 mL PBS, before being subjected to three freeze-thaw cycles and brief sonication with an ultrasonic processor set at 35% amplitude (Cole-Parmer; Vernon Hills, IL, USA). Eyes, heart, spleen, intestine, kidneys, and blood were placed in 200 μL PBS before being subjected to three freeze-thaw cycles and brief sonication. Serial dilutions of the organ homogenate were prepared in gel saline to a total inoculum volume of 200 μL. Viral adsorption proceeded for 1 h before L929s were overlayed with 1.5% Agar/2×199 media. Cells were overlayed again at 4 dpi. On 7 dpi, both layers of agar/media were gently removed and remaining cells fixed and stained with 0.3% methylene blue in 5% formalin. Plaques were counted and the reported pfu per milliliter value was calculated by correcting for inoculum volume and dilution factors.
Lactate dehydrogenase assay
Lactate dehydrogenase (LDH) efflux is commonly used as a measurement of injury in organotypic slices (Bruce et al. 1995; Noraberg et al. 1999) . BSC media was collected at various times post-infection and triplicate 10-μl samples were analyzed with the LDH-Cytotoxicity Assay Kit II (Biovision; Mountain View, CA, USA) in which water was used as a blanking control and purified LDH used as a positive control. LDH activity was quantified on a microplate reader (Molecular Devices Emax; Sunnyvale, CA, USA) as a function of the optical density measured at 450 nm with wavelength correction at 650 nm.
Fluorogenic Caspase 3 activity assay Caspase 3 activity was determined by utilizing a fluorogenic assay (B&D Biosciences; San Jose, CA, USA). Activated Caspase 3 hydrolyzes the synthetic peptide substrate Ac-DEVD-7-amino-4-trifluoromethyl coumarin (AFC) resulting in the generation of a fluorescent reporter molecule AFC. The reaction product was measured on a Cytofluor Series 4000 spectrofluorometer (Applied Biosystems; Carlsbad, CA, USA) at excitation wavelength of 450 nm and emission wavelength of 530 nm.
Statistical analysis
All bar graphs are presented as mean ± SD. Numbers of independent experiments are indicated by the N value. All statistical analyses were performed using Instat and Prism software (GraphPad Software Inc., San Diego, CA, USA). Statistical comparisons between two groups (i.e., mock vs. infected or B6wt vs. IFNAR −/− ) were made using a two-tailed, unpaired t test with Welch correction. For survival studies, the mean day of death ± standard deviation was calculated for each group of mice. Differences in survival were calculated using a logrank (Mantel-Cox) test. Probability values of p<0.05 were considered significant differences and denoted as such with asterisks.
